Cantor Fitzgerald, L. P.
Source: SEC Form 13F · as of Mar 2026Cantor Fitzgerald, L. P. holds 15 biotech & pharma companies tracked by BioSniper, totaling $20.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$20.1M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Immunocore Holdings plc (IMCR)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| IMCRImmunocore Holdings plc | 250,211 | $7.5M |
| RNAAtrium Therapeutics Inc. | 235,637 | $3.2M |
| INSMINSMED Inc | 11,000 | $1.8M |
| ACOGAlpha Cognition Inc. | 188,631 | $1.0M |
| SLNOSOLENO THERAPEUTICS INC | 30,000 | $1.0M |
| RCUSArcus Biosciences, Inc. | 45,000 | $972K |
| PTHSPelthos Therapeutics Inc. | 41,423 | $870K |
| ANTXAN2 Therapeutics, Inc. | 200,000 | $684K |
| TLPHTALPHERA, INC. | 887,481 | $663K |
| TRDAEntrada Therapeutics, Inc. | 47,000 | $593K |
| MRNAModerna, Inc. | 10,009 | $508K |
| OKUROnKure Therapeutics, Inc. | 99,900 | $414K |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | 40,098 | $377K |
| AARDAardvark Therapeutics, Inc. | 66,682 | $251K |
| CLYMClimb Bio, Inc. | 30,000 | $206K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.